Omnes Capital's exits

Sector 
Pharma
Entry Date 
2006
Exit Date 
2009
Buyer 
Acquisition of a Pangenetics asset by Abbott
Business 
Venture Capital

PanGenetics

Development of innovative and unique humanised therapeutic antibodies.

Dutch company specialised in the clinical development of therapeutic antibodies. The company sold exclusive rights to its PG-110 antibody to Abbott for $190 million. Developed by PanGenetics, PG-110 is a humanised antibody targeting nerve growth factor (in phase I clinical trials). To date, the company has raised close to €51 million in the three funding rounds completed between 2005 and 2008. The deal is an endorsement of the company’s novel strategy predicated on the development of proprietary products and the licensing of new products, excluding R&D activities.

Sector 
Pharma
Entry Date 
2005
Exit Date 
2009
Buyer 
Sanofi Aventis
Business 
Venture Capital

Fovea Pharmaceuticals

Ocular franchise dedicated to discovering therapies for retinal conditions

Founded in 2005 to break new ground in the treatment of retinal conditions, Fovea Pharmaceuticals has built an R&D portfolio covering ocular conditions with unmet needs, and now forms Sanofi’s Ophthalmology division. Its core approach is to put patients at the heart of its strategy, thanks to its presence at the Institut de la Vision located on the Quinze-Vingts hospital campus. Its team consists almost exclusively of research scientists. 
The company was bought by Sanofi Aventis in 2009 in a deal worth up to €370 million.

 

Sector 
Pharma
Entry Date 
2004
Exit Date 
2009
Buyer 
Pharma Omnium International
Business 
Venture Capital

Mutabilis

Discovery of new therapeutic targets for the development of anti-infectives

Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.

Sector 
Business services
Entry Date 
2002
Exit Date 
2009
Business 
Mid-Cap Buyout & Growth Capital

Ortec

One of the leading providers of industrial, energy and environmental services

The Ortec group provides a broad range of multidisciplinary and complementary services encompassing maintenance, construction works, environmental services, facilities management and logistics, engineering and project owner assistance.

Sector 
Business services
Entry Date 
2006
Exit Date 
2009
Buyer 
Pragma Capital, Gimv aux côtés du management
Business 
Mezzanine Buyout & Growth Capital

Leyton & Associés

Tax and payroll charge consulting

Leyton provides payroll charge and tax consulting services with a focus on three business lines: payroll charge reductions, research tax credit (known as the CIR in France) and reductions in occupational accident contributions. The group has focused on small businesses (fewer than 1,000 employees) because they are not generally well catered for by the major players in the sector.

Sector 
Independent power producer
Entry Date 
2008
Exit Date 
2009
Buyer 
cession industrielle
Business 
Renewable Energy

Conexia Energy

Headquartered in Aix-en-Provence, Conexia Energy is a renewable energy consulting and engineering company specialised in the development of ground-based solar photovoltaic power plants. Conexia Energy has a project portfolio of over 70 MWp in installed capacity in France.

Sector 
Consumer goods
Entry Date 
2006
Exit Date 
2008
Buyer 
GameStop
Business 
Mezzanine Buyout & Growth Capital

Micromania

Specialist in video games distribution

The Micromania group is a specialist distributor of video games and consoles and operates a network of branches and franchised stores in shopping centres and city-centre locations. The Group bolstered its coverage of city-centre locations by acquiring its rival Dock Games.  

Sector 
Industry
Entry Date 
2003
Exit Date 
2008
Buyer 
IFP Investissements
Business 
Small-Cap Buyout & Growth Capital

Heurtey Petrochem

International oil and gas engineering group

Founded in 1953, Heurtey Petrochem is an international oil and gas engineering group operating in two market segments: 1) process furnaces for refining, petrochemicals, and hydrogen production, an area in which Heurtey Petrochem is a world leader, 2) natural gas treatment through its Prosernat subsidiary.

Sector 
Industry
Entry Date 
2005
Exit Date 
2008
Buyer 
LFPI
Business 
Mid-Cap Buyout & Growth Capital

Ital Express

Spare parts specialist

Distribution of spare parts for heavy goods vehicles and agricultural tractors to hauliers, garage owners, dealers, agents and resellers

Sector 
Business services
Entry Date 
2000
Exit Date 
2008
Buyer 
Argos Soditic
Business 
Small-Cap Buyout & Growth Capital

Lexsi

Independent information systems security and cybersecurity consulting firm

Pursuing a strategy focused on innovation, what sets the group apart is a unique combination of technologies, methods and talent, all geared towards protecting the interests of its clients

Pages

NewsRoom
Publication
Omnes Capital Newsletter n°31: Green building news H1 2017
Press release
30 May 2017
Building on its initial success in the US, AB Tasty Raises $17 million in Series B Funding
Building on its initial success in the US, AB Tasty Raises $17 million in Series B Funding
Press release
15 May 2017
Omnes Capital launches new FCPI fund: Capital Invest PME 2017
Omnes Capital launches new FCPI fund: Capital Invest PME 2017
Press release
04 May 2017
Omnes Capital acquires a minority core shareholding in the Batiweb Group via a capital development transaction

Omnes Capital acquires a minority core shareholding in the Batiweb Group via a capital development transaction
Publication
Omnes Capital Newsletter n°31: renewable energy news H1 2017
Press release
24 April 2017
Omnes Capital took part in a €4 million fundraising round of portuguese startup 360imprimir
Omnes Capital took part in a €4 million fundraising round of portuguese startup 360imprimir

Pages